Trial intelligence / Profile preview

PG2 in Chronic ITP

NCT00860600Phase 2Completed

Sponsor
PhytoHealth Corporation
Start
Sep 2008
Primary completion
Aug 2011
Modality
PE (Plant Extract)
Countries
1
01

Overview

A Phase 2 trial of astragalus polysaccharides in immune thrombocytopenia (ITP), sponsored by PhytoHealth Corporation. Started Sep 2008; status: completed.

02

Drugs

astragalus polysaccharides
03

Conditions

immune thrombocytopenia (ITP)

Beyond the preview

Go deeper on NCT00860600.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00860600.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call